RETRACTION: PRMT5 Participates in B Cell Overactivation in Patients With Primary Sjogren's Syndrome (pSS) Through RSAD2‐Mediated NF‐κB Signaling. This evidence concerns the gene RSAD2 and peeling skin syndrome.